Resolving a chronic inflammation mystery
Nature Medicine 23, 914 (2017).
doi:10.1038/nm.4384
Authors: Ben Roediger & Wolfgang Weninger
Using interleukin (IL)-9-deficient mice, Rauber and colleagues unveil a crucial role for group 2 innate lymphoid cells (ILC2s) in the resolution phase of arthritic inflammation, opening up new therapeutic avenues for chronic inflammatory disease.
Source: Nature Medicine - Category: General Medicine Authors: Ben Roediger Wolfgang Weninger Tags: News and Views Source Type: research